Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients

计划入组 8 人 · 首次发布于 2008 年 4 月 15 日

Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes

计划入组 132 人 · 首次发布于 2010 年 8 月 19 日

Duke APOL1 Research Biorepository

计划入组 200 人 · 首次发布于 2019 年 11 月 13 日

ABCA1/ApoA1 (Gilead Palo Alto)

APOL1 inhibitor (kidney disease)

ApoA-1(Tome Biosciences)

Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Linking Spectris Neuromodulation to Lipid Transport and Myelination Pathways in Alzheimer's Disease

Obicetrapib Shows Promise in Phase 3 BROADWAY Trial, Reduces LDL-C and MACE

Metabolic Signatures Predict Immunotherapy Response in Metastatic Melanoma Patients